Literature DB >> 18273698

Implications for a regulated replication of Borna disease virus in brains of experimentally infected Lewis rats.

Doris Porombka1, Wolfgang Baumgärtner, Markus Eickmann, Christiane Herden.   

Abstract

The neurotropic Borna disease virus (BDV) causes typically a persistent virus infection of the central nervous system. In order to investigate whether an adapted virus replication contributes to BDV persistence in vivo, a fast and reliable real-time RT-PCR assay was constructed to quantify the amounts of leader-containing (leBDV) as a marker for virus replication, genomic (vBDV) and nucleoprotein-(BDV-N +ssRNA)-specific RNA. Therefore, leBDV, vBDV and BDV-N +ssRNA values were determined in experimentally infected Lewis rats between 14 and 90 days post infection (dpi). Surprisingly low leBDV values were found compared to vBDV and the abundantly expressed BDV-N transcripts. vBDV multiplied only in the acute phase of infection followed by constant expression until 90 dpi. Ratios of vBDV to leBDV were 401:1 at 14 dpi and diminished to 209:1 at 90 dpi, indicating a regulated co-expression of replicative intermediates as a potential prerequisite for viral persistence.

Entities:  

Mesh:

Year:  2008        PMID: 18273698     DOI: 10.1007/s11262-008-0210-8

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  22 in total

Review 1.  Novel insights into the regulation of the viral polymerase complex of neurotropic Borna disease virus.

Authors:  Urs Schneider
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

2.  Genomic organization of Borna disease virus.

Authors:  T Briese; A Schneemann; A J Lewis; Y S Park; S Kim; H Ludwig; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 3.  Replication strategies of rabies virus.

Authors:  Stefan Finke; Karl-Klaus Conzelmann
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

4.  Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain.

Authors:  C Herden; S Herzog; J A Richt; A Nesseler; M Christ; K Failing; K Frese
Journal:  Brain Pathol       Date:  2000-01       Impact factor: 6.508

5.  Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells.

Authors:  P Staeheli; M Sentandreu; A Pagenstecher; J Hausmann
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 6.  Molecular biology of Borna disease virus and persistence.

Authors:  Juan Carlos de la Torre
Journal:  Front Biosci       Date:  2002-02-01

7.  Functional characterization of the genomic promoter of borna disease virus (BDV): implications of 3'-terminal sequence heterogeneity for BDV persistence.

Authors:  Debralee Rosario; Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Conservation of coding potential and terminal sequences in four different isolates of Borna disease virus.

Authors:  Stephan Pleschka; Peter Staeheli; Jolanta Kolodziejek; Jürgen A Richt; Norbert Nowotny; Martin Schwemmle
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

9.  Borna disease virus induces acute fatal neurological disorders in neonatal gerbils without virus- and immune-mediated cell destructions.

Authors:  Makiko Watanabe; Byeong-Jae Lee; Makiko Yamashita; Wataru Kamitani; Takeshi Kobayashi; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  Virology       Date:  2003-06-05       Impact factor: 3.616

10.  Overlapping signals for transcription and replication at the 3' terminus of the vesicular stomatitis virus genome.

Authors:  T Li; A K Pattnaik
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  1 in total

1.  Genomic RNAs of Borna disease virus are elongated on internal template motifs after realignment of the 3' termini.

Authors:  Arnold Martin; Nadja Hoefs; Josefine Tadewaldt; Peter Staeheli; Urs Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.